TCM
IONS icon

Traynor Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Traynor Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-6,200
Closed -$356K – 135
2015
Q2 		$356K Sell
6,200
-3,675
-37% -$234K 0.3% 74
2015
Q1 		$628K Buy
+9,875
New +$670K 0.6% 34

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Traynor Capital Management's IONS Position: Q3 2015 in Review

Traynor Capital Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2015, closing a stake of 6,200 shares — an estimated $356K sold.

Traynor Capital Management first reported a position in IONS in Q1 2015 and held it in 2 quarters. The position peaked at $628K in Q1 2015. 314 funds tracked by Wall St. Rank hold IONS as of Q3 2015.

  • Traynor Capital Management reported no remaining Ionis Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Traynor Capital Management sold 6,200 Ionis Pharmaceuticals shares in Q3 2015, an estimated $356K.
  • Traynor Capital Management first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 2 quarters.
  • Traynor Capital Management's Ionis Pharmaceuticals position peaked at $628K in Q1 2015.
  • 314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2015.

Based on Traynor Capital Management's 13F filing for Q3 2015, filed 23 Feb 2016.